Healthcare · Drug Manufacturers - Specialty & Generic
Celltrion Pharm, Inc.
068760KRX₩36,650−₩150 (−0.41%)Market closed
Price Chart
Daily
Key facts
- Market Cap
- ₩1.63T
- P/E
- 41.1x
- P/B
- 3.65x
- ROE
- 9.3%
Celltrion Pharm, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic · FY 2025
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.
- CEO
- 유영호
- Employees
- 0
- Website
- celltrionph.com
Company Statistics
Valuation
P/E
41.1x
P/B
3.65x
P/S
2.97x
EV/EBITDA
21.3x
P/FCF
23.2x
Margins
Gross
30.5%
EBITDA
14.9%
Operating
10.5%
Pre-Tax
9.3%
Net
7.2%
Returns
ROA
5.4%
ROE
9.3%
ROIC
7.9%
Growth (CAGR)
Rev 3Yr
11.6%
Rev 5Yr
18.1%
Op Inc 3Yr
13.7%
Net Inc 3Yr
14.3%
Financial Health
Cash & Cash Equivalents
₩49.87B
Net Debt
₩273.61B
Debt/Equity
74.2%
Interest Cov
—
Profile
Revenue
₩536.40B
Shares Out
44.4M